2019
DOI: 10.56093/ijans.v89i6.91104
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of MDR and ESBL-producing E. coli strains from healthy swine herds of north-eastern India

Abstract: Fecal samples (225) from apparently healthy pigs were analysed for E. coli isolation. Multidrug-resistant (MDR) isolates (42) were identified from 225 E. coli isolates. Forty isolates exhibited extended-spectrum beta-lactamases (ESBL) phenotype harbouring single to multiple-sized plasmids (1 kb to ≥ 25 kb). Overall blaTEM (85.7%) was the commonest genotype, followed by blaCTX-M (61.9%), blaOXA (17%) and blaSHV was not recovered. Other antimicrobial resistant genes (ARGs) identified were sul2 (100%), strA (95… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…Antibiotic resistance is directly related to the decrease in number of effective antibiotics available for the treatment of bacterial infections (Dobiasova et al 2013;Conrad et al 2017). Resistance to 1 st to 4 th generation cephalosporins is due to the production of extended spectrum betalactamases (ESBL), inhibited by clavulanic acid, sulbactam and tazobactam (Sanjukta et al 2019;Raheel et al 2022). The ESBLs are plasmid-mediated enzymes which hydrolyze and inactivate a range of β-Lactam antibiotics including aztreonam, penicillin & broadspectrum cephalosporin (Al-Muharrmi et al 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Antibiotic resistance is directly related to the decrease in number of effective antibiotics available for the treatment of bacterial infections (Dobiasova et al 2013;Conrad et al 2017). Resistance to 1 st to 4 th generation cephalosporins is due to the production of extended spectrum betalactamases (ESBL), inhibited by clavulanic acid, sulbactam and tazobactam (Sanjukta et al 2019;Raheel et al 2022). The ESBLs are plasmid-mediated enzymes which hydrolyze and inactivate a range of β-Lactam antibiotics including aztreonam, penicillin & broadspectrum cephalosporin (Al-Muharrmi et al 2008).…”
Section: Introductionmentioning
confidence: 99%